Antidepressants in pregnancy increase miscarriage risk

Antidepressants in pregnancy increase risk of miscarriage – There is a 68% increase in the overall risk of miscarriage in pregnant women using antidepressants, found a new study in CMAJ (Canadian Medical Association Journal).

Exposure to bacteria can increase learning behavior

Can bacteria make you smarter? — Exposure to bacteria can increase learning behavior. – Exposure to specific bacteria in the environment, already believed to have antidepressant qualities, could increase learning behavior according to research presented today at the 110th General Meeting of the American Society for Microbiology in San Diego.

Acupuncture lessens depression symptoms during pregnancy

Acupuncture lessens depression symptoms during pregnancy, Stanford study shows – Acupuncture appears to be an effective way to reduce depression symptoms during pregnancy, according to a first-of-its-kind study from Stanford University School of Medicine researchers.

Antidepressant drugs may lead to lactation difficulties in moms

Common antidepressant drugs linked to lactation difficulties in moms – Women taking commonly used forms of antidepressant drugs may experience delayed lactation after giving birth and may need additional support to achieve their breastfeeding goals.

Few Americans receive adequate treatment for depression

Few Americans with major depression receive adequate treatment – Many U.S. adults with major depression do not receive treatment for depression or therapy based on treatment guidelines, and some racial and ethnic groups have even lower rates of adequate depression care.

Restless leg syndrome linked with erectile dysfunction in older men

Study links restless leg syndrome with erectile dysfunction in older men – Erectile dysfunction was more common in older men with restless leg syndrome (RLS) than in those without RLS, and the magnitude of this association increased with a higher frequency of RLS symptoms, revealed by researchers.

Antidepressants may raise stroke risk in postmenopausal women

Study finds increased risk of death, stroke in postmenopausal women taking antidepressants — Findings signal need for individual risk assessment, additional study – Women participating in the Women’s Health Initiative study who reported taking an antidepressant drug had a small but statistically significant increase in the risk of stroke and of death compared with participants not taking antidepressants.

Antidepressant may change personality while relieving symptoms

Antidepressant may change personality while relieving symptoms – Individuals taking a medication to treat depression may experience changes in their personality separate from the alleviation of depressive symptoms, according to a report in the December issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Learn to deal with inattentive, hyperactive & impulsive kids

ATTENTION PARENTS AND TEACHERS! LEARN TO DEAL WITH INATTENTIVE, HYPERACTIVE & IMPULSIVE KIDS – ADHD is a disorder of the brain and behavior. It affects about 3 to 5% of children. The symptoms start before seven years of age. Global prevalence for children is approximately 5%, with wide variability dependent on research methodologies utilized in studies.

Boxed warning required for Chantix and Zyban, says FDA

FDA: Boxed Warning on Serious Mental Health Events to be Required for Chantix and Zyban – Smoking cessation drugs Chantix and Zyban are causing unusual changes in behavior, depression, and suicidal thinking in those who have taken these drugs to quit their smoking habits.

Primitive lifestyle elements ease depression

Embracing your primitive nature can help in fight against depression – KU researcher finds primitive lifestyle elements ease depression. – He doesn’t care for the term “caveman therapy.” But Stephen Ilardi, associate professor of clinical psychology at the University of Kansas, has turned to our hunter-gatherer ancestors for clues about how to best combat major depressive disorder.

Positive clinical trial results of vilazodone for depression

Clinical Data, Inc. Announces Positive Results from Second Phase III Trial of Vilazodone for Depression – Clinical Data, Inc. (NASDAQ: CLDA) announced positive top-line results from the second of two Phase III trials of its investigational compound, vilazodone, for the treatment of major depressive disorder (MDD).

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | SpiritIndia